Zauderer, Majorie

Publications

Sort by

Co-Author Network

selected publications

Integrative Molecular Characterization of Malignant Pleural Mesothelioma. Cancer discovery. 2018 Academic Article GET IT
Times cited: 327
Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2018 Conference Paper GET IT
Times cited: 71
Malignant Pleural Mesothelioma: Are There Imaging Characteristics Associated With Different Histologic Subtypes on Computed Tomography?. Journal of computer assisted tomography. 2018 Academic Article GET IT
Times cited: 4
A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Academic Article GET IT
Times cited: 39
Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1. Oncotarget. 2017 Academic Article GET IT
Times cited: 26
Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy. Immunotherapy. 2017 Review GET IT
Times cited: 35
Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis. Molecular cancer therapeutics. 2017 Academic Article GET IT
Times cited: 24
Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma. International journal of radiation oncology, biology, physics. 2017 Academic Article GET IT
Times cited: 17
Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2017 Academic Article GET IT
Times cited: 39
Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study. International journal of cancer. 2017 Academic Article GET IT
Times cited: 28
Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 125
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization. 2016 GET IT
Times cited: 95
Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power?. The Lancet. Oncology. 2016 Letter GET IT
Times cited: 21
Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Academic Article GET IT
Times cited: 87
Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers. PloS one. 2016 Academic Article GET IT
Times cited: 15
A new standard for malignant pleural mesothelioma. Lancet (London, England). 2015 Comment GET IT
Times cited: 8
Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2015 Academic Article GET IT
Times cited: 51
Localized malignant pleural mesothelioma with renal metastasis. 2015 GET IT
A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage I to IIIA non-small-cell lung cancers. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2014 Academic Article GET IT
Times cited: 31
Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase. Lung cancer (Amsterdam, Netherlands). 2014 Academic Article GET IT
Times cited: 44
Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma. International journal of radiation oncology, biology, physics. 2014 Academic Article GET IT
Times cited: 46
Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma. Lung cancer (Amsterdam, Netherlands). 2014 Academic Article GET IT
Times cited: 77
Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2013 Academic Article GET IT
Times cited: 68
Toxicity of initial chemotherapy in older patients with lung cancers. Journal of geriatric oncology. 2013 Academic Article GET IT
Times cited: 17
Important recent insights into the genetics and biology of malignant pleural mesothelioma. Annals of cardiothoracic surgery. 2012 Academic Article GET IT
Pleurectomy/decortication, chemotherapy, and intensity modulated radiation therapy for malignant pleural mesothelioma: rationale for multimodality therapy incorporating lung-sparing surgery. Annals of cardiothoracic surgery. 2012 Academic Article GET IT
New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Academic Article GET IT
Times cited: 66
Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. International journal of radiation oncology, biology, physics. 2012 Academic Article GET IT
Times cited: 120
Novel therapies in phase II and III trials for malignant pleural mesothelioma. Journal of the National Comprehensive Cancer Network : JNCCN. 2012 Review GET IT
Times cited: 21
The evolution of multimodality therapy for malignant pleural mesothelioma. Current treatment options in oncology. 2011 Academic Article GET IT
Times cited: 35
Leptomeningeal metastases from small cell lung cancer responsive to temozolomide therapy. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2010 Letter GET IT
Times cited: 5
Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer. Breast cancer research and treatment. 2008 Academic Article GET IT
Times cited: 43
Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005 Academic Article GET IT
Times cited: 505
Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Breast cancer research and treatment. 2005 Academic Article GET IT
Times cited: 45
Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Drugs & aging. 2005 Academic Article GET IT
Times cited: 14

more ...

less ...

Background

education and training

M.D., Columbia University College of Physicians and Surgeons 2006
B.S., Yale University 2001
M.S., Yale University 2001

Contact

full name

Majorie Zauderer

VIVO Weill Cornell Medical College

Majorie Zauderer Associate Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name